comscore CDC panel meets Tuesday to vote on COVID-19 vaccine priority | Honolulu Star-Advertiser
Top News

CDC panel meets Tuesday to vote on COVID-19 vaccine priority

  • ASSOCIATED PRESS
                                Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus at the Kaiser Permanente Washington Health Research Institute in Seattle in March. A panel of U.S. advisers will meet this week to recommend who should be first in line for a COVID-19 vaccine.

    ASSOCIATED PRESS

    Neal Browning receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus at the Kaiser Permanente Washington Health Research Institute in Seattle in March. A panel of U.S. advisers will meet this week to recommend who should be first in line for a COVID-19 vaccine.

ATLANTA >> A panel of U.S. advisers will meet Tuesday to vote on how scarce, initial supplies of a COVID-19 vaccine will be given out once one has been approved.

Experts have proposed giving the vaccine to health workers first. High priority also may be given to workers in essential industries, people with certain medical conditions and people age 65 and older.

Tuesday’s meeting is for the Advisory Committee on Immunization Practices, a group established by the Centers for Disease Control and Prevention. The panel of experts recommends who to vaccinate and when — advice that the government almost always follows. The agenda for next week’s emergency meeting was posted Friday.

Pfizer and its German partner BioNTech have asked the Food and Drug Administration to allow emergency use of its COVID-19 vaccine candidate. Moderna Inc. is expected to also seek emergency use of its vaccine soon.

FDA’s scientific advisers are holding a public meeting Dec. 10 to review Pfizer’s request, and send a recommendation to the FDA.

Manufacturers already have begun stockpiling coronavirus vaccine doses in anticipation of eventual approval, but the first shots will be in short supply and rationed.

Comments (2)

By participating in online discussions you acknowledge that you have agreed to the Terms of Service. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. Report comments if you believe they do not follow our guidelines.

Having trouble with comments? Learn more here.

Click here to see our full coverage of the coronavirus outbreak. Submit your coronavirus news tip.

Be the first to know
Get web push notifications from Star-Advertiser when the next breaking story happens — it's FREE! You just need a supported web browser.
Subscribe for this feature

Scroll Up